On the codetermination of tax-financed medical R&amp;D and healthcare expenditures: Models and evidence

Batinti, Alberto

doi:10.1016/j.ejpoleco.2018.03.006

Cited by 20 publications

(3 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11 Mandates (m) that increase positive externalities while reducing material comforts can be modelled with essentially the same equations by replacing the tax price (T) with the personal cost (C) of a mandate (m), "C = c(m)", and writing the aggregate externality X as a function of m rather than S. Inexpensive mandates supported by monetary penalties could be represented with an expected fine function similar to the tax function assumed. However, modeling positive externalities associated with the R&D efforts of firms and scientists that tend to bring effective vaccines to markets more quickly would require a more complex model, similar to that developed in Batinti and Congleton (2018). The purpose of the modelling exercise in this paper is to demonstrate that policy disagreements are likely among even similarly well-informed individuals, rather than to fully characterize the political economy of healthcare systems.…”

Section: Support For Subsidies Of Behaviors That Have Positive Externalitiesmentioning

confidence: 99%

Federalism and pandemic policies: variety as the spice of life

Congleton

2021

Public Choice

Self Cite

View full text Add to dashboard Cite

In the ordinary course of life, choices vary with age and other factors because one's opportunities vary with one's circumstances. Thus, investments in and expenditures on healthcare (and most other things) vary with age and a variety of other factors, including whether one lives in a rural area, suburb, or central city, health risks, risk aversion, and beliefs about the nature of a good life. Because assessment of the effects of illnesses vary with the same factors, the conclusions reached about best private and governmental health policies also tend to vary. This implies that conformity to "ideal" pandemic policies is more likely to be generated by a federal or polycentric system of policy making than a unitary system, especially ones that are constrained by a generality principle.

show abstract

Section: Support For Subsidies Of Behaviors That Have Positive Externalitiesmentioning

confidence: 99%

Federalism and pandemic policies: variety as the spice of life

Congleton

2021

Public Choice

Self Cite

View full text Add to dashboard Cite

show abstract

“…Hence, the healthcare industry is related to well-being and has enormous improvement potential [1]. Innovation is essential for the healthcare industry, because it will not only broaden the area of healthcare treatment, but also enhance the productivity of existing therapy, fulfilling the increasing demand [2].…”

Section: Introductionmentioning

confidence: 99%

The Impact of the R&D Investments towards Short-term Corporate Valuation -- Evidence from Chinese Listed Healthcare Companies

Chen¹

2022

BCPBM

View full text Add to dashboard Cite

R&D investments impact the corporate valuation in the healthcare industry, and the outbreak of COVID-19 influences their relationship. This paper applied simple linear regression to analyse the influence of R&D investments on corporate valuation among Chinese listed healthcare companies, showing an enormous difference between R&D intensity and personnel. R&D intensity will have a negative relationship with corporate valuation in the current year, while R&D personnel will positively influence it. Further, after the pandemic outbreak, the nexus between corporate valuation and R&D intensity transferred into positive, while its R&D personnel counterpart is still not significant. These results display that it is essential for Chinese listed healthcare companies to improve corporate valuation through altering their R&D policy, such as recruiting R&D personnel, paying attention to R&D investments and their effectiveness, and learning the experience from the epidemic outbreak. In addition, this paper also enriches the literature review of R&D spending and corporate valuation.

show abstract

“…Exceptions are the book The Politics of Innovation byTaylor (2016), the historical view byMokyr (1998) about the obstacles towards innovations, and some recent work on public research in the health sector(Batinti and Congleton, 2018).…”

mentioning

confidence: 99%

The political economy of public research, or why some governments commit to research more than others

Filippetti

Vezzani

2022

Technological Forecasting and Social Change

View full text Add to dashboard Cite

The broad consensus about the benefits of public research is at odds with the fact that investment is in general declining but with different patterns across countries. This triggers our research question: why do some governments invest in public research more than others? By relying on political economy literature, we frame investment in public research as a political choice depending on the political institutions of countries. Based on an empirical analysis on 41 countries we find a robust relationship between public-funded research and political institutions. Countries with parliamentary forms of government, proportional electoral rules and bicameralism devote larger shares of GDP and of public expenditure to research. We also find a great role of encompassing civic society organizations in encouraging public research. Political economy offers a promising perspective to delve into the patterns of public research. As for policy implications, majoritarian-like reforms might discourage long-term policies and harm the long-term potential for economic growth.

show abstract

On the codetermination of tax-financed medical R&D and healthcare expenditures: Models and evidence

Cited by 20 publications

References 14 publications

Federalism and pandemic policies: variety as the spice of life

Federalism and pandemic policies: variety as the spice of life

The Impact of the R&D Investments towards Short-term Corporate Valuation -- Evidence from Chinese Listed Healthcare Companies

The political economy of public research, or why some governments commit to research more than others

Contact Info

Product

Resources

About